As the Chief Executive Officer of Cloudbreak Pharma, Inc., Jinsong Ni brings over 25 years of extensive experience in the pharmaceutical industry and academic research, particularly in drug discovery and development. Under his leadership, Cloudbreak Pharma has established a pioneering vision focused on the GLOBAL...
As the Chief Executive Officer of Cloudbreak Pharma, Inc., Jinsong Ni brings over 25 years of extensive experience in the pharmaceutical industry and academic research, particularly in drug discovery and development. Under his leadership, Cloudbreak Pharma has established a pioneering vision focused on the GLOBAL MARKET and GLOBAL NEW initiatives, specifically targeting the treatment of significant unmet ocular diseases. Jinsong has successfully assembled a world-class team of experts in ocular drug discovery and development, fostering an environment that prioritizes innovation and scientific excellence.
One of Jinsong's key achievements has been raising over US$150 million from private equity funds, which has enabled Cloudbreak Pharma to advance its innovative drug pipelines. His expertise in molecular biology, pharmacokinetics, and drug metabolism has been instrumental in guiding the company through complex phases of drug development, ensuring that each candidate is rigorously evaluated for efficacy and safety. Furthermore, Jinsong's strategic vision has led to the establishment of strong collaborations with contract research organizations (CROs) and academic institutions, enhancing the company's research capabilities and accelerating the path to market for its therapies.
Jinsong's commitment to addressing unmet medical needs in the ocular space is not only a reflection of his professional background but also his passion for improving patient outcomes. As Cloudbreak Pharma continues to expand its portfolio, Jinsong remains dedicated to leveraging his extensive knowledge in life sciences and pharmaceutics to drive the company’s mission forward, ultimately transforming the landscape of ocular disease treatment on a global scale.
